Paget's disease of the breast differential diagnosis: Difference between revisions
Preeti Singh (talk | contribs) No edit summary |
Preeti Singh (talk | contribs) No edit summary |
||
Line 29: | Line 29: | ||
! colspan="2" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Para-clinical findings | ! colspan="2" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Para-clinical findings | ||
| rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold Standard | | rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold Standard | ||
| | | rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Associated factors''' | ||
|- | |- | ||
! colspan="7" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Symptoms | ! colspan="7" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Symptoms | ||
! colspan="2" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physical examination | ! colspan="2" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physical examination | ||
|- | |- | ||
!style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings | ||
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology | ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology | ||
|- | |- | ||
Line 61: | Line 61: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
** | ** | ||
|align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | Nl | | align="center" style="background:#F5F5F5;" | Nl | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
Line 72: | Line 72: | ||
* [[Superinfection]] with bacteria and [[candida]] | * [[Superinfection]] with bacteria and [[candida]] | ||
Generalized seborrheic [[erythroderma]] in immunodeficient patients | Generalized seborrheic [[erythroderma]] in immunodeficient patients | ||
| align="center" style="background:#F5F5F5;" | | |||
|align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
|align="center" style="background:#F5F5F5;" | | |||
|- | |- | ||
! rowspan="21" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Skin disorders | ! rowspan="21" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Skin disorders | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Atopic dermatitis]] | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Atopic dermatitis]] | ||
|align="center" style="background:#F5F5F5;" |Benign | | align="center" style="background:#F5F5F5;" |Benign | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Epidermal barrier dysfunction | * Epidermal barrier dysfunction | ||
Line 114: | Line 113: | ||
* Dyskeratosis | * Dyskeratosis | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| | | align="center" style="background:#F5F5F5;" | | ||
* | * | ||
* [[Family history]] of [[atopic dermatitis]] or other [[atopy]] | * [[Family history]] of [[atopic dermatitis]] or other [[atopy]] | ||
Line 126: | Line 125: | ||
* Skin [[inflammation]] mediated by [[Haptens|hapten]]-specific T cells | * Skin [[inflammation]] mediated by [[Haptens|hapten]]-specific T cells | ||
| align="center" style="background:#F5F5F5;" | Erythematous well-demarcated [[papules]] | | align="center" style="background:#F5F5F5;" | Erythematous well-demarcated [[papules]] | ||
|align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" |– | | align="center" style="background:#F5F5F5;" |– | ||
| align="center" style="background:#F5F5F5;" |May be multiple after 1-2 days of exposure | | align="center" style="background:#F5F5F5;" |May be multiple after 1-2 days of exposure | ||
Line 132: | Line 131: | ||
| align="center" style="background:#F5F5F5;" | Surrounding the area in contact with the offending agent | | align="center" style="background:#F5F5F5;" | Surrounding the area in contact with the offending agent | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
|align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Stinging and burning | * Stinging and burning | ||
Line 142: | Line 141: | ||
* [[Exocytosis]] of [[eosinophils]] and [[lymphocytes]] | * [[Exocytosis]] of [[eosinophils]] and [[lymphocytes]] | ||
* Chronic - [[Hyperkeratosis]] and parakeratosis | * Chronic - [[Hyperkeratosis]] and parakeratosis | ||
|align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| | | align="center" style="background:#F5F5F5;" | | ||
* Contact with [[allergens]] in the past 1-2 days | * Contact with [[allergens]] in the past 1-2 days | ||
* Positive [[family history]] | * Positive [[family history]] | ||
|- | |- | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Psoriasis]] | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Psoriasis]] | ||
|align="center" style="background:#F5F5F5;" |Benign | | align="center" style="background:#F5F5F5;" |Benign | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* [[Keratinocyte]] hyperproliferation | * [[Keratinocyte]] hyperproliferation | ||
* Dysregulation of the [[immune system]] | * Dysregulation of the [[immune system]] | ||
| align="center" style="background:#F5F5F5;" | Well-circumscribed, pink [[papules]] and symmetrically distributed cutaneous [[plaques]] with silvery scales | | align="center" style="background:#F5F5F5;" | Well-circumscribed, pink [[papules]] and symmetrically distributed cutaneous [[plaques]] with silvery scales | ||
|align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" | Multiple | | align="center" style="background:#F5F5F5;" | Multiple | ||
Line 163: | Line 162: | ||
* Extensor surface of elbows and knees | * Extensor surface of elbows and knees | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
|align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* [[Auspitz's sign]] (pinpoint bleeding) | * [[Auspitz's sign]] (pinpoint bleeding) | ||
Line 171: | Line 170: | ||
* Parakeratosis | * Parakeratosis | ||
* [[Neutrophils]] microabscesses (Munro microabscesses) | * [[Neutrophils]] microabscesses (Munro microabscesses) | ||
|align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| | | align="center" style="background:#F5F5F5;" |Risk factors include | ||
* [[Smoking]] | * [[Smoking]] | ||
* Skin trauma | * Skin trauma | ||
Line 345: | Line 344: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" |+ | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Localized [[inflammation]] of [[breast]] | * Localized [[inflammation]] of [[breast]] | ||
Line 383: | Line 382: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" |+ | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" |± | | align="center" style="background:#F5F5F5;" |± |
Revision as of 16:56, 21 February 2019
Paget's disease of the breast Microchapters |
Differentiating Paget's disease of the breast from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Paget's disease of the breast differential diagnosis On the Web |
American Roentgen Ray Society Images of Paget's disease of the breast differential diagnosis |
Paget's disease of the breast differential diagnosis in the news |
Blogs on Paget's disease of the breast differential diagnosis |
Directions to Hospitals Treating Paget's disease of the breast |
Risk calculators and risk factors for Paget's disease of the breast differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Suveenkrishna Pothuru, M.B,B.S. [2]
Overview
Paget's disease of the breast must be differentiated from atopic dermatitis, eczema, psoriasis, malignant melanoma, Bowen's disease, basal cell carcinoma, and pagetoid dyskeratosis.[1][2]
Differential Diagnosis
Paget’s disease of the breast must be differentiated from other benign and malignant processes of nipple-areola complex such as:[1][2]
- Atopic dermatitis
- Chronic contact dermatitis
- Lactiferous duct ectasia
- Chronic eczema
- Psoriasis
- Nipple duct adenoma
- Malignant melanoma
- Bowen’s disease
- Superficial basal cell carcinoma
- Pagetoid basal cell carcinoma
- Benign intraductal papilloma
- Pagetoid dyskeratosis
Category | Diseases | Benign or Malignant | Etiology | Clinical manifestations | Para-clinical findings | Gold Standard | Associated factors | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Symptoms | Physical examination | |||||||||||||||
Lab Findings | Histopathology | |||||||||||||||
Rash | Nipple Discharge | Erythema | Single/
Multiple |
Involved areas | Mastalgia | Breast Exam | Other | Serum IgE | ||||||||
Eczema | Scalp, face, trunk, postauricular, diaper area and axilla | + | – | + |
|
Nl |
|
Risk factors include
Generalized seborrheic erythroderma in immunodeficient patients |
||||||||
Skin disorders | Atopic dermatitis | Benign |
|
– | Multiple | + |
|
– |
|
↑ |
|
| ||||
Allergic contact dermatitis[3] | Benign |
|
Erythematous well-demarcated papules | – | May be multiple after 1-2 days of exposure | + | Surrounding the area in contact with the offending agent | + |
|
Nl |
|
| ||||
Psoriasis | Benign |
|
Well-circumscribed, pink papules and symmetrically distributed cutaneous plaques with silvery scales | + | Multiple | + |
|
+ |
|
Nl |
|
Risk factors include
| ||||
Malignant melanoma | ||||||||||||||||
Bowen’s disease | ||||||||||||||||
Superficial basal cell carcinoma | ||||||||||||||||
Pagetoid basal cell carcinoma | ||||||||||||||||
Benign intraductal papilloma | ||||||||||||||||
Pagetoid dyskeratosis | ||||||||||||||||
Lactiferous duct ectasia | Benign | * Common among perimenopausalwomen
|
* Distention of subareolar ducts | Ultrasound:
|
||||||||||||
Nipple duct adenoma | ||||||||||||||||
Benign Toker cell hyperplasia | ||||||||||||||||
Breast abscess | Benign | + |
|
|
||||||||||||
Mondors disease | ||||||||||||||||
Mastitis |
|
+ | ± |
|
|
|||||||||||
Inflammatory Breast Cancer |
References
- ↑ 1.0 1.1 Gaspari, Eleonora; Ricci, Aurora; Liberto, Valeria; Scarano, Angela Lia; Fornari, Maria; Simonetti, Giovanni (2013). "An Unusual Case of Mammary Paget's Disease Diagnosed Using Dynamic Contrast-Enhanced MRI". Case Reports in Radiology. 2013: 1–5. doi:10.1155/2013/206235. ISSN 2090-6862.
- ↑ 2.0 2.1 Lopes Filho, Lauro Lourival; Lopes, Ione Maria Ribeiro Soares; Lopes, Lauro Rodolpho Soares; Enokihara, Milvia M. S. S.; Michalany, Alexandre Osores; Matsunaga, Nobuo (2015). "Mammary and extramammary Paget's disease". Anais Brasileiros de Dermatologia. 90 (2): 225–231. doi:10.1590/abd1806-4841.20153189. ISSN 1806-4841.
- ↑ Nosbaum A, Vocanson M, Rozieres A, Hennino A, Nicolas JF (2009). "Allergic and irritant contact dermatitis". Eur J Dermatol. 19 (4): 325–32. doi:10.1684/ejd.2009.0686. PMID 19447733.